⭐ BESTSELLER
🏥 NABL ACCREDITED
Maternal Screen-2nd Trimester Triple Marker Test
This prenatal screening evaluates AFP, hCG, and unconjugated estriol levels in maternal serum during the second trimester. It helps assess the risk of chromosomal abnormalities such as Down syndrome and neural tube defects. The test serves as an important non-invasive tool for prenatal risk estimation and further diagnostic planning.
29 hrs
Report Ready
No Fasting
Fasting
20-99
Age Group
Home
Collection
Preparation
Why this test
Fasting Required
Not Required
⏱ Report Time
29 hrs
🧫 Sample Type
Blood
🎂 Age Group
20-99
👤 Gender
Female
🏠 Collection
Home Visit
Valid between 14 to 22 weeks gestation (Ideal 15 to 20 weeks)
(Includes *AFP *BETA HCG *Free Estriol *Risk Evaluation) The Triple Screen test is used for Prenatal Screening of Down Syndrome (Trisomy 21), Edward’s Syndrome (Trisomy 18) and Open Neural Tube Defects. Please provide recent ultrasound with maternal Date of birth (dd/mm/yy); LMP ; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy along with other details in digital Maternal screening form.
